Showing results (231-240 of 287) with videos related to

Sort By:
Pageof 29
Frontiers in Immunology|May 4, 2026
New proteomic biomarkers identified in plasma extracellular vesicles in sarcoidosis: a case-control matched studyRunzhen Zhao, Nan Miles Xi, Lea Gabby, et al.
Chest|November 6, 2018
ICU Admission Muscle and Fat Mass, Survival, and Disability at Discharge: A Prospective Cohort StudyAriel Jaitovich, Malik M H S Khan, Ria Itty, et al.
Circulation|April 18, 2024
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart AssociationRichard K Cheng, Michelle M Kittleson, Craig J Beavers, et al.
Respiratory Medicine and Research|July 31, 2024
Sarcoidosis Diagnostic Score (SDS) system: Impact of race, sex, organ involvement and duration of symptoms prior to diagnosisYing Zhou, Florence Jeny, Violetta Vucinic, et al.
Frontiers in Immunology|August 4, 2026
Correction: New proteomic biomarkers identified in plasma extracellular vesicles in sarcoidosis: a case-control matched studyRunzhen Zhao, Nan Miles Xi, Gabrielle Lea, et al.
Lancet (London, England)|May 17, 2011
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trialsPaul W Noble, Carlo Albera, Williamson Z Bradford, et al.
Respiratory Medicine|April 22, 2017
The role of serum amyloid A staining of granulomatous tissues for the diagnosis of sarcoidosisAlbert Huho, Llewellyn Foulke, Timothy Jennings, et al.
American Journal of Respiratory and Critical Care Medicine|December 7, 2010
Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important differenceRoland M du Bois, Derek Weycker, Carlo Albera, et al.
American Journal of Respiratory and Critical Care Medicine|September 24, 2011
Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important differenceRoland M du Bois, Derek Weycker, Carlo Albera, et al.
Pageof 29